Recent Company News

• 11:28 PM ET Apr 06, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (102 total)

• 10:02 PM ET Mar 05, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 11:33 PM ET Feb 06, 2025
  

  AGC revises 2026 targets; operating profit ¥180.0B vs prior guidance ¥230.0B (¥4173.0000, -224)

• 11:14 PM ET Feb 06, 2025
  

  AGC reports FY net income attributable (¥94.04B) vs FactSet (¥94.00B) [10 est, (¥99.09)-(86.50B)] (¥4259.0000, -138)

• 09:16 PM ET Dec 11, 2024
  

  NEC Bio presents promising interim results from ongoing Phase 1 basket clinical trial of NECVAX-NEO1

• 12:35 AM ET Nov 25, 2024
  

  AGC signs MoU with Chubu Hydrogen and Ammonia Social Implementation Promotion Council to build supply chain for hydrogen, ammonia, etc. in Chubu region (¥4643.0000, +20)

• 08:35 PM ET Nov 08, 2024
  

  AGC downgraded to B from B+ at Mito Securities (¥4762.0000, 0)

• 12:04 AM ET Nov 01, 2024
  

  AGC reports 9M net income attributable (¥106.41B) vs year-ago ¥57.54B (¥4714.0000, +12)

• 08:29 PM ET Sep 23, 2024
  

  AGC, CompleCure enter into strategic service agreement for advanced anti-cancer therapeutic (¥4518.0000, +71)

• 10:23 PM ET Sep 10, 2024
  

  AGC, MEDINET sign strategic partnership agreement for cell therapy CDMO business (¥4347.0000, -56)